[PHARMA] YoY Annualized Quarter Result on 30-Sep-2022 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- -13.15%
YoY- -57.23%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 3,486,232 3,530,609 5,471,062 2,787,317 2,806,462 2,384,416 2,281,018 7.32%
PBT -54,298 76,732 202,649 65,732 62,145 77,706 70,930 -
Tax -4,310 -24,536 -86,596 -21,310 -23,097 -26,160 -27,065 -26.36%
NP -58,609 52,196 116,053 44,421 39,048 51,546 43,865 -
-
NP to SH -59,641 49,430 115,566 45,093 39,172 50,708 42,697 -
-
Tax Rate - 31.98% 42.73% 32.42% 37.17% 33.67% 38.16% -
Total Cost 3,544,841 3,478,413 5,355,009 2,742,896 2,767,414 2,332,869 2,237,153 7.96%
-
Net Worth -245,740 411,327 391,428 345,040 516,387 522,618 531,892 -
Dividend
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Div - 33,185 75,056 34,852 29,557 48,535 44,973 -
Div Payout % - 67.14% 64.95% 77.29% 75.46% 95.71% 105.33% -
Equity
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Net Worth -245,740 411,327 391,428 345,040 516,387 522,618 531,892 -
NOSH 1,441,229 1,309,126 1,309,126 261,705 261,229 260,505 259,821 33.03%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -1.68% 1.48% 2.12% 1.59% 1.39% 2.16% 1.92% -
ROE 0.00% 12.02% 29.52% 13.07% 7.59% 9.70% 8.03% -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
RPS 259.62 269.52 417.92 1,066.33 1,076.09 917.05 879.14 -18.38%
EPS -4.44 3.77 8.83 17.25 15.01 19.51 16.45 -
DPS 0.00 2.53 5.73 13.33 11.33 18.67 17.33 -
NAPS -0.183 0.314 0.299 1.32 1.98 2.01 2.05 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
RPS 241.89 244.97 379.61 193.40 194.73 165.44 158.27 7.32%
EPS -4.14 3.43 8.02 3.13 2.72 3.52 2.96 -
DPS 0.00 2.30 5.21 2.42 2.05 3.37 3.12 -
NAPS -0.1705 0.2854 0.2716 0.2394 0.3583 0.3626 0.3691 -
Price Multiplier on Financial Quarter End Date
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Date 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 -
Price 0.435 0.515 0.835 4.32 2.44 2.89 4.14 -
P/RPS 0.17 0.19 0.20 0.41 0.23 0.32 0.47 -15.58%
P/EPS -9.79 13.65 9.46 25.04 16.25 14.82 25.16 -
EY -10.21 7.33 10.57 3.99 6.16 6.75 3.97 -
DY 0.00 4.92 6.87 3.09 4.64 6.46 4.19 -
P/NAPS 0.00 1.64 2.79 3.27 1.23 1.44 2.02 -
Price Multiplier on Announcement Date
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Date 29/11/23 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 15/11/17 -
Price 0.405 0.55 0.845 5.72 2.21 3.09 3.82 -
P/RPS 0.16 0.20 0.20 0.54 0.21 0.34 0.43 -15.18%
P/EPS -9.12 14.58 9.57 33.16 14.71 15.84 23.21 -
EY -10.97 6.86 10.45 3.02 6.80 6.31 4.31 -
DY 0.00 4.61 6.79 2.33 5.13 6.04 4.54 -
P/NAPS 0.00 1.75 2.83 4.33 1.12 1.54 1.86 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment